Document is current
Any future updates will be listed below
-
Authors
Agius, Rudi
Riis-Jensen, Anders C.
Wimmer, Bettina http://orcid.org/0009-0002-7229-950X
da Cunha-Bang, Caspar
Murray, Daniel Dawson
Poulsen, Christian Bjorn http://orcid.org/0000-0001-9785-1378
Bertelsen, Marianne B.
Schwartz, Berit
Lundgren, Jens Dilling http://orcid.org/0000-0001-8901-7850
Langberg, Henning
Niemann, Carsten Utoft http://orcid.org/0000-0001-9880-5242
- License Information
-
More Information
Article History
Received: 7 November 2023
Accepted: 8 May 2024
First Online: 5 June 2024
Competing interests
: C.U.N. received research funding and/or consultancy fees from AstraZeneca, Janssen, AbbVie, Genmab, Beigene, Octapharma, C.S.L. Behring, Takeda, MSD and Lilly, Alfred Benzon Foundation, Novo Nordisk Foundation, EU-funded CLL-CLUE, and Danish Cancer Society, but declares no financial or non-financial competing interests. DDM received funding from the Danish National Research Foundation (DNRF 126), but declares no financial or non-financial competing interests. The remaining authors declare no competing interests.
